8 employees
SmartDyeLivery develops and provides a platform for nano-formulated drugs to restore critical cellular signaling functions.
2016
SmartDyeLivery raised undisclosed on October 10, 2018
Investors: bm-t beteiligungsmanagement thüringen GmbH